首页> 外文会议>MEDINFO >Which Patients may benefit from the Use of a Decision Support System to Improve Compliance of Physician Decisions with Clinical Practice Guidelines: A Case Study with Breast Cancer involving Data Mining
【24h】

Which Patients may benefit from the Use of a Decision Support System to Improve Compliance of Physician Decisions with Clinical Practice Guidelines: A Case Study with Breast Cancer involving Data Mining

机译:哪些患者可以从使用决策支持系统中受益,从临床实践指南提高医生决策的遵守情况:以涉及数据挖掘的乳腺癌为例

获取原文

摘要

OncoDoc2 is a guideline-based clinical decision support system (CDSS) for breast cancer management. It has been used as an intervention in a randomized controlled trial carried out to evaluate the impact of using a CDSS upon the compliance with clinical practice guidelines (CPGs) of multidisciplinary staff meeting decisions. Data mining was used to discover multi-criteria regularities as "emerging patterns " (EPs) associated with compliance and non-compliance with CPGs when using and not using OncoDoc2 and to assess which patients may benefit from the use of the CDSS. Decision data was collected from all participating centers. The number of EPs associated with non-compliance is smaller in the intervention arm, which suggests a practice harmonization effect of OncoDoc2. EPs associated with compliant decisions in both arms of the trial correspond to situations well identified in CPGs. EPs associated with non-compliant decisions when the system is not used are associated with compliance when the system is used except in clinical situations where evidence is lacking.
机译:OncoDoc2是乳腺癌管理基于指南的临床决策支持系统(CDSS)。它已被用作一个随机对照试验的干预进行评估在与多学科的员工会议上决定临床实践指南(日用消费品)的合规使用CDSS的影响。数据挖掘被用来发现多标准规律性与合规性和不遵守使用和不使用OncoDoc2和评估哪些患者可能从使用CDSS中受益时日用消费品相关的“新兴模式”(EPS)。数据决定从所有参与中心收集。不遵守相关的EPS的数目是在介入臂,这表明OncoDoc2的实践协调效果小。与标准的决定在审判对应的两个武器的情况相关的EPS日用消费品以及标识。当使用除了证据不足,其中临床情况下,系统在不使用的系统不符合要求的决策相关的EP与合规相关的。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号